Press Releases

Noted Diagnostic Industry Veteran David B. Perez Joins as an Independent Director. Chris Smith Appointed Chairman of the Board, in addition to current CEO role. Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that David B.
Sep 01, 2020
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a worldwide reputation for top-rated customer service and support, today announced that its Ortho Care™ holistic service and support program was ranked No. 1 in the diagnostics industry for a fifth straight year.
Jul 21, 2020
RARITAN, N.J. (July 6, 2020) – Ortho Clinical Diagnostics, a global leader of in vitro diagnostics backed by The Carlyle Group, announced Joseph M. Busky has joined the Company as Chief Financial Officer, effective July 7, 2020. Busky, who previously served as Chief Financial Officer for Vyaire
Jul 06, 2020
Ortho’s COVID-19 total antibody test receives CE Mark  Ortho’s total antibody test may be used as aid in diagnosis and to support decisions for getting people back to work The test offers excellent performance, with 100 percent specificity and sensitivity Ortho began shipping its antibody test to
May 12, 2020
Ortho announces FDA Emergency Use Authorization received for its second COVID-19 antibody test Similar to Ortho's total COVID-19 antibody test, Ortho's IgG test demonstrated  100% specificity  and can be used to support decisions for getting people back to work  Ortho has already begun shipping its
Apr 25, 2020
Displaying 21 - 30 of 102